Han Zhu
- Hematology top 10%
- Acute Myeloid Leukemia Research 13
- Hematopoietic Stem Cell Transplantation 3
- Multiple Myeloma Research and Treatments 2
-
- CAR-T cell therapy research 3
-
- Acute Lymphoblastic Leukemia research 4
-
- Protein Degradation and Inhibitors 3
- Histone Deacetylase Inhibitors Research 3
-
- Myeloproliferative Neoplasms: Diagnosis and Treatment 2
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Han Zhu
23 papers receiving 384 citations
Peers
Comparison fields: 5 of 72
- Hematology 103
- Nutrition and Dietetics 55
- Cancer Research 52
- Oncology 80
- Complementary and Manual Therapy 6
Countries citing papers authored by Han Zhu
This map shows the geographic impact of Han Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han Zhu more than expected).
Fields of papers citing papers by Han Zhu
This network shows the impact of papers produced by Han Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han Zhu. The network helps show where Han Zhu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Han Zhu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 12 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 4 | |
| 8 | 2021 | 41 | |
| 9 | 2021 | 3 | |
| 10 | 2020 | 13 | |
| 11 | 2020 | 21 | |
| 12 | 2018 | 1 | |
| 13 | 2018 | 85 | |
| 14 | 2018 | 11 | |
| 15 | Effects of chidamide and its combination with decitabine on proliferation and apoptosis of leukemia cell lines. | 2018 | 28 |
| 16 | 2017 | 0 | |
| 17 | 2017 | 2 | |
| 18 | 2016 | 20 | |
| 19 | Effect of autophagy-related gene Beclin 1 on growth of xenografts of human lung adenocarcinoma A549 cells in nude mice | 2011 | 1 |
| 20 | 2006 | 53 |
About Han Zhu
Han Zhu is a scholar working on Hematology, Genetics and Transplantation, having authored 29 papers that have together received 386 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (13 papers), Acute Lymphoblastic Leukemia research (4 papers), CAR-T cell therapy research (3 papers), Protein Degradation and Inhibitors (3 papers), Histone Deacetylase Inhibitors Research (3 papers), Hematopoietic Stem Cell Transplantation (3 papers), Multiple Myeloma Research and Treatments (2 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). The work is most often cited by research in Hematology (103 citations), Nutrition and Dietetics (55 citations) and Cancer Research (52 citations). Han Zhu has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Jianyong Li, Sixuan Qian, Ming Hong, Huihui Zhao, Shuai Wang, Jianping Mao, Ninghan Tang, Bao Wang, Bin Zhou and Lulu Yang. Their work appears in journals such as Journal of Clinical Oncology, Blood and Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.